Go Pro
→ Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (From Paradigm Press) (Ad)tc pixel Free ENTA Stock Alerts

Enanta Pharmaceuticals (ENTA) Earnings Date, Estimates & Call Transcripts

Enanta Pharmaceuticals logo
$13.16 -0.28 (-2.08%)
Closing price 04:00 PM Eastern
Extended Trading
$13.15 -0.01 (-0.08%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Enanta Pharmaceuticals Earnings Summary

Enanta Pharmaceuticals released Q3 2026 earnings on August 10, 2026, reporting an EPS of -$0.67, which missed the consensus estimate of -$0.51 by $0.16. Quarterly revenue was reported to be $14.36 million, below analysts' expectations of $16.76 million. With a trailing EPS of -$2.41, Enanta Pharmaceuticals' earnings are expected to decrease next year, from ($1.94) to ($1.99) per share.

Latest Q3
Earnings Date
Aug. 10Confirmed
Consensus EPS
(Aug. 10)
-$0.51
Actual EPS
(Aug. 10)
-$0.67 Missed By -$0.16
Actual Revenue
(Aug. 10)
$14.36M

Q3 2026 Earnings Resources

Powered by Quartr
Get Enanta Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enanta Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ENTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENTA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Enanta Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.53-$0.53-$0.53
Q2 20261-$0.51-$0.51-$0.51
Q3 20261-$0.51-$0.51-$0.51
Q4 20261-$0.95-$0.95-$0.95

Enanta Pharmaceuticals Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/10/2026Q3 2026-$0.5095-$0.67 -$0.1605-$0.67$16.76M$14.36M
5/11/2026Q2 2026-$0.46-$0.45+$0.01-$0.45$17.03M$17.16M
2/9/2026Q1 2026-$0.54-$0.42+$0.12-$0.42$16.14M$18.62M
11/17/2025Q4 2025-$1.13-$0.87+$0.26-$0.87$15.60M$15.13M
8/11/2025Q3 2025-$1.25-$0.85+$0.40-$0.85$16.21M$18.31M
5/12/2025Q2 2025-$1.04-$1.06 -$0.02-$1.06$15.96M$14.93M
2/10/2025Q1 2025-$1.16-$1.05+$0.11-$1.05$17.25M-
11/25/2024Q4 2024-$1.16-$1.36 -$0.20-$1.36$17.99M$14.60M

Enanta Pharmaceuticals Earnings - Frequently Asked Questions

Enanta Pharmaceuticals (NASDAQ:ENTA) last announced its quarterly earning data on Monday, August 10, 2026. Learn more on ENTA's earnings history.

In the previous quarter, Enanta Pharmaceuticals (NASDAQ:ENTA) missed the analysts' consensus estimate of ($0.51) by $0.16 with a reported earnings per share (EPS) of ($0.67). Learn more on analysts' earnings estimate vs. ENTA's actual earnings.

Enanta Pharmaceuticals (NASDAQ:ENTA) has a recorded annual revenue of $65.26 million.

Enanta Pharmaceuticals (NASDAQ:ENTA) has a recorded net income of -$81.89 million. ENTA has generated -$2.41 earnings per share over the last four quarters.

Enanta Pharmaceuticals' earnings are expected to decrease from ($1.94) per share to ($1.99) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:ENTA is sourced from Fiscal.ai, with the most recent quarter reported on 8/10/2026. New results are added as companies report their earnings.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
AI insiders stockpile guns, gold & gas masks
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel
$100 for this… $500 for that. Here’s how to stop the bleeding today
Rising costs are squeezing households nationwide. USA Today reports more families are moving in together, whil...
Brownstone Research | Sponsoredtc pixel